Clinical trials
Acute Hospitalization clinical trials
Below are recruiting acute hospitalization clinical trials, each written for real people, not researchers. We’re tracking 981 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06009315Recruiting
Stroke treatment outcome prediction study
This study looks at patients having a stroke procedure to remove a clot. It aims to predict how well people recover. If you are having this treatment, the study might help doctors understand your likely outcome.
Beijing, Beijing MunicipalityAges 18–100 - NCT06329999Recruiting
CMGV for recurrent AML and high-risk MDS
This study tests a new treatment called CMGV for adults whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) has returned or is not improving. It is for people who may be older or have had other blood disorders.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06188195Recruiting
Preventing newborn breathing problems with steroids
This study tests a plan to prevent a severe newborn breathing problem called NARDS. If your baby's risk is very high, you may be offered a steroid treatment that could help their lungs work better at birth.
ChongqingAges Any age - NCT06976099Enrolling by invitation
Studying pancreatitis caused by high triglycerides
This study looks at people with acute pancreatitis caused by very high blood fat levels (triglycerides). It aims to collect information to better understand and treat this condition.
Beijing, Beijing MunicipalityAges 18–80 - NCT07170085Recruiting
Positioning for babies with breathing problems
This trial tests if different body positions help babies under 1 year old with breathing problems breathe better while on oxygen support (High-Flow or CPAP).
OdenseAges Up to 1 year - NCT05000801Recruiting
DC-AML cells for AML after remission but with relapse risk
This study tests DC-AML immune cells to help people with acute myeloid leukemia (AML) who are in remission but still show signs of leftover cancer cells or relapse risk. It may help the immune system attack AML cells, especially when a stem cell transplant is not an option.
Beijing, Beijing MunicipalityAges 18–70 - NCT05519579RecruitingPhase 2
Spinal chemotherapy to help protect the brain during blinatumomab
This trial studies giving medicine into the spinal fluid (intrathecal chemotherapy) to lower the risk of brain/nerve side effects from blinatumomab. It’s for adults with certain types of B-cell acute lymphoblastic leukemia (ALL) who are starting their first cycle.
Atlanta, GeorgiaAges 18 years+ - NCT05694624Recruiting
Study of sepsis-related kidney injury monitoring
This trial looks at acute kidney injury that can happen during sepsis (a serious body-wide infection or suspected infection). It may help improve how doctors detect and manage kidney problems early, especially in intensive care or around major surgery.
Tromsø, TromsAges 18–100 - NCT06139692RecruitingPhase 4
Comparing light sedation during clot removal for stroke
This study compares two types of light sedation (medication to help you relax) during a procedure to remove a blood clot in the brain after a stroke. The goal is to find which sedation method helps patients recover better.
Nanjing, None SelectedAges 18 years+ - NCT06898944Recruiting
Acute Kidney Injury: Risk Factors and Outlook
This study looks back at adults who visited certain hospitals in South Korea to understand what leads to acute kidney injury (a sudden drop in kidney function) and how it affects recovery. It compares people who had this condition with similar people who did not, to identify risk factors.
SeoulAges 20 years+ - NCT07097753Enrolling by invitation
Comparing two surgeries for infected pancreatic necrosis
This trial compares a newer, minimally invasive surgery (MIPPED-C) with standard open surgery (OSN) for treating infected pancreatic necrosis. It aims to see which approach leads to better recovery and outcomes.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05983172Enrolling by invitation
Genomic risk study for new AML patients
This study uses advanced genetic analysis to better understand risk in people newly diagnosed with acute myeloid leukemia (AML) at a specific hospital. It may help tailor future treatments.
TaipeiAges 18 years+ - NCT03234296Enrolling by invitation
Antibiotics versus placebo for uncomplicated appendicitis
This trial tests whether taking antibiotics alone can treat acute uncomplicated appendicitis, compared with a placebo. If antibiotics work, it may help some people avoid surgery or reduce treatment intensity.
TurkuAges 18–60 - NCT06881498Recruiting
Blood thinning technique for bone tumor surgery
This trial tests a technique called 'acute normovolemic hemodilution' during bone tumor surgery. It involves temporarily thinning your blood by removing some red blood cells and replacing them with fluid, which may reduce the need for blood transfusions.
Hangzhou, ZhejiangAges 18–75 - NCT06562478Recruiting
Meditation after heart attack study
This study tests whether regular Zazen (a type of seated meditation) can help people recover better after a recent heart attack. You would attend meditation sessions at the hospital twice a week for several weeks.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT06711003Recruiting
Enhanced circulation therapy for recent stroke recovery
This trial tests whether a non-invasive treatment that boosts blood flow can help people recovering from a stroke. If you had a stroke within the last month and have moderate to moderately severe disability, you may be eligible to participate and potentially improve your recovery.
TaichungAges 20 years+ - NCT05247502Recruiting
Study of kidney outcomes after ICU kidney injury
This study follows adults who stay in the ICU for more than 24 hours to see how an episode of acute kidney failure affects kidney health over the long term. Your participation helps researchers understand which ICU patients may need closer kidney monitoring later.
Clermont-FerrandAges 18 years+ - NCT06459141Recruiting
Blood Thinning During Bone Tumor Surgery
This study tests whether a technique that thins your blood during surgery can help people having bone tumor removal. It may reduce the need for blood transfusions.
Hangzhou, ZhejiangAges 18–75 - NCT07521969Recruiting
Outpatient care after emergency appendix removal surgery
This trial tests whether patients with a specific type of appendix infection (gangrenous appendicitis) can safely recover at home instead of staying in the hospital after surgery. The goal is to see if home-based care with close follow-up visits works as well as traditional hospital stays.
Seville, SevillaAges 14 years+ - NCT06469801Recruiting
Detecting brain injury in children on ECMO
This research study uses a portable MRI machine to look for brain injuries in children on or at high risk for ECMO, a heart-lung support machine. The goal is to detect problems early so doctors can treat them quickly.
Kansas City, MissouriAges birth–17 years - NCT07643597Recruiting
Managing fluid removal in critically ill patients with acute kidney injury
This study looks at how to safely remove excess fluid from patients in the ICU who have sudden kidney failure and are on a special blood-filtering machine (CRRT). Researchers want to understand which patients have trouble tolerating fluid removal and how to prevent complications.
SalvadorAges 18 years+ - NCT06643962Recruiting
Venetoclax plus strong chemo for AML with slow blast clearance
This trial tests adding venetoclax (a targeted pill) to strong chemotherapy for people with newly diagnosed AML. It is for those whose leukemia cells do not clear quickly enough after standard induction therapy, to see if the combination helps them achieve remission.
Nantong, JiangsuAges 18–70 - NCT07397650RecruitingPhase 4
Early finerenone for heart failure in hospital
This trial tests if starting finerenone early helps patients hospitalized with heart failure who have symptoms like shortness of breath or swelling. It aims to see if the drug is safe and effective when given soon after admission.
Handa, Aichi-kenAges 18 years+ - NCT06636955Recruiting
Bronchiolitis viruses after nirsevimab in infants
This study looks at how well the new nirsevimab vaccine works against bronchiolitis in babies. If your infant has their first bout of bronchiolitis and gets a nose swab, they may be able to help researchers understand how the virus spreads and how to better protect other babies.
RouenAges birth–1 year
Hear when a new Acute Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for acute hospitalization?
- Yes. Clin2 currently lists 981 recruiting acute hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a acute hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a acute hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.